Golden Tan

Beijing Golden-Tan Biotechnology is a prominent Chinese biopharmaceutical company specializing in the development and large-scale manufacture of recombinant protein therapeutics. Established in 1993 as a subsidiary of the North China Pharmaceutical Group (NCPC), the company was a pioneer in China's biotechnology sector, becoming one of the first domestic firms to successfully commercialize recombinant human erythropoietin (rhEPO). Its product portfolio primarily focuses on hematology and oncology supportive care, with flagship brands such as Jintan for anemia and Jinsheng for chemotherapy-induced neutropenia. Golden-Tan operates advanced GMP-certified manufacturing facilities in Beijing, utilizing sophisticated recombinant DNA and protein purification technologies. The company plays a critical role in providing essential biologic treatments within the Chinese healthcare system and continues to expand its presence in the supportive care market.